{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:52:28Z","timestamp":1773085948638,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health of Italy"},{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006676","name":"EU","doi-asserted-by":"publisher","award":["295552"],"award-info":[{"award-number":["295552"]}],"id":[{"id":"10.13039\/100006676","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Marie Curie Grant","award":["IRG 247918"],"award-info":[{"award-number":["IRG 247918"]}]},{"name":"Netherlands Genomics Initiative","award":["NGI\/NWO 05040202"],"award-info":[{"award-number":["NGI\/NWO 05040202"]}]},{"name":"FIRB","award":["RBFR13P392"],"award-info":[{"award-number":["RBFR13P392"]}]},{"name":"EBRI-Rita Levi Montalcini Foundation Research Programme in Metabolism in Brain Diseases"},{"name":"LAM-Bighi Research Grant on Brain Tumours"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.mito.2014.09.008","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T18:48:55Z","timestamp":1411930135000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"PA","title":["Type 2 Transglutaminase, mitochondria and Huntington's disease: Menage a trois"],"prefix":"10.1016","volume":"19","author":[{"given":"Sara","family":"Altuntas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"D'Eletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Rossin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Diaz","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Farrace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Falasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Piredda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Giorgio","family":"Mastroberardino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelangelo","family":"Campanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2014.09.008_bb0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.mito.2014.09.008_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00726-011-1188-4","article-title":"Recent advances in the development of tissue transglutaminase (TG2) inhibitors","volume":"44","author":"Badarau","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.mito.2014.09.008_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 Mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.mito.2014.09.008_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1471-4159.2006.04140.x","article-title":"Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders","volume":"100","author":"Battaglia","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2014.09.008_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00726-004-0091-7","article-title":"The transglutaminase family: an overview: minireview article","volume":"26","author":"Beninati","year":"2004","journal-title":"Amino Acids"},{"key":"10.1016\/j.mito.2014.09.008_bb0030","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1096\/fj.01-0689com","article-title":"Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient","volume":"16","author":"Bernassola","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.mito.2014.09.008_bb0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mito.2014.09.008_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmet.2008.06.001","article-title":"Regulation of mitochondrial structure and function by the F1 Fo-ATPase inhibitor protein, IF1","volume":"1","author":"Campanella","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2014.09.008_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tibs.2009.03.006","article-title":"IF1: setting the pace of the F1 Fo-ATP synthase","volume":"7","author":"Campanella","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.mito.2014.09.008_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbabio.2009.02.023","article-title":"IF1, the endogenous regulator of the F1 Fo-ATPsynthase, defines mitochondrial volume fraction in HeLa cells by regulating autophagy","volume":"5","author":"Campanella","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2014.09.008_bb0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.40.6.581","article-title":"Biochemical aspects of Huntington's chorea","volume":"40","author":"Caraceni","year":"1977","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.mito.2014.09.008_bb0060","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mito.2014.09.008_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1242\/jcs.064576","article-title":"The regulation of autophagy \u2014 unanswered questions","volume":"124","author":"Chen","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mito.2014.09.008_bb0065","doi-asserted-by":"crossref","first-page":"11884","DOI":"10.1073\/pnas.182276099","article-title":"Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2014.09.008_bb0080","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4161\/auto.5.8.10040","article-title":"Transglutaminase 2 is involved in autophagosome maturation","volume":"5","author":"D'Eletto","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.mito.2014.09.008_bb0075","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/cdd.2012.2","article-title":"Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins","volume":"19","author":"D'Eletto","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mito.2014.09.008_bb0085","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4161\/auto.25367","article-title":"Ca2+ in quality control: an unresolved riddle critical to autophagy and mitophagy","volume":"9","author":"East","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.mito.2014.09.008_bb0090","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1196371","article-title":"Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy","volume":"331","author":"Egan","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.mito.2014.09.008_bb0095","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/cdd.2012.163","article-title":"IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling","volume":"20","author":"Faccenda","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mito.2014.09.008_bb0100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0968-0004(02)02182-5","article-title":"Transglutaminase 2: an enigmatic enzyme with diverse functions","volume":"27","author":"Fesus","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.mito.2014.09.008_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2007.01.026","article-title":"Impaired metabolism-secretion coupling in pancreatic beta-cells: role of determinants of mitochondrial ATP production","volume":"77","author":"Fujimoto","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.mito.2014.09.008_bb0110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pharmthera.2011.12.003","article-title":"Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications","volume":"133","author":"Grosso","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mito.2014.09.008_bb0115","doi-asserted-by":"crossref","DOI":"10.1096\/fj.14-251413","article-title":"Transglutaminase 2 exacerbates \u03b1-synuclein toxicity in mice and yeast","author":"Grosso","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.mito.2014.09.008_bb9000","series-title":"Intracellular localization and conformational state of transglutaminase 2: implications for cell death. PLoS One 4","author":"Gundemir","year":"2009"},{"key":"10.1016\/j.mito.2014.09.008_bb0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1042\/bj20021084","article-title":"A novel function of tissue-type transglutaminase: protein disulphide isomerase","volume":"373","author":"Hasegawa","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.mito.2014.09.008_bb0125","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1158\/1078-0432.CCR-05-2305","article-title":"Intracellular protein degradation and its therapeutic implications","volume":"11","author":"Hideshima","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mito.2014.09.008_bb0140","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.274.43.30715","article-title":"Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease","volume":"274","author":"Kim","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2014.09.008_bb0145","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s11064-005-8796-x","article-title":"Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain","volume":"30","author":"Kim","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.mito.2014.09.008_bb0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.abb.2007.03.034","article-title":"Selective degradation of mitochondria by mitophagy","volume":"462","author":"Kim","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mito.2014.09.008_bb0135","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2014.09.008_bb0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00281-012-0305-0","article-title":"Role of transglutaminase 2 in celiac disease pathogenesis","volume":"34","author":"Kl\u00f6ck","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.mito.2014.09.008_bb0155","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/CIRCRESAHA.112.265819","article-title":"Mitochondria and mitophagy: the yin and yang of cell death control","volume":"111","author":"Kubli","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.mito.2014.09.008_bb0160","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4161\/auto.25413","article-title":"Genome-wide RNAi screen identifies ATPase inhibitory factor 1 (ATPIF1) as essential for PARK2 recruitment and mitophagy","volume":"11","author":"Lefebvre","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.mito.2014.09.008_bb0165","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1046\/j.1471-4159.2000.0751951.x","article-title":"Impaired mitochondrial function results in increased tissue transglutaminase activity in situ","volume":"75","author":"Lesort","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2014.09.008_bb0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mito.2014.09.008_bb0175","first-page":"146860","article-title":"Adenine nucleotide translocase, mitochondrial stress, and degenerative cell death","author":"Liu","year":"2013","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.mito.2014.09.008_bb0180","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrm1014","article-title":"Transglutaminases: crosslinking enzymes with pleiotropic functions","volume":"4","author":"Lorand","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mito.2014.09.008_bb0185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/138161208783413220","article-title":"Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection","volume":"14","author":"Malorni","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mito.2014.09.008_bb0190","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/cdd.2009.100","article-title":"The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis","volume":"16","author":"Malorni","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mito.2014.09.008_bb0195","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(07)70076-5","article-title":"Autophagy and neurodegeneration: when the cleaning crew goes on strike","volume":"6","author":"Martinez-Vicente","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mito.2014.09.008_bb0200","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2796.2010.02275.x","article-title":"Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential","volume":"268","author":"Mastroberardino","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mito.2014.09.008_bb0205","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.bbabio.2006.07.007","article-title":"\u201cTissue\u201d transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes","volume":"1757","author":"Mastroberardino","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2014.09.008_bb0210","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.mito.2014.09.008_bb0215","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.200809125","article-title":"Parkin is recruited selectively to impaired mitochondria and promotes their autophagy","volume":"183","author":"Narendra","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mito.2014.09.008_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394305-7.00001-X","article-title":"Cellular functions of tissue transglutaminase","volume":"294","author":"Nurminskaya","year":"2012","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.mito.2014.09.008_bb0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jnc.12441","article-title":"Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1","volume":"128","author":"Oono","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2014.09.008_bb0230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0014-5793(85)80611-6","article-title":"Interaction between the mitochondrial ATP synthetase and ATPase inhibitor protein: active\/inactive slow pH-dependent transitions of the inhibitor protein","volume":"2","author":"Panchenko","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mito.2014.09.008_bb0235","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00726-010-0500-z","article-title":"Transglutaminase 2: a multi-functional protein in multiple subcellular compartments","volume":"39","author":"Park","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.mito.2014.09.008_bb0240","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1471-4159.2002.00898.x","article-title":"Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress","volume":"81","author":"Piacentini","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2014.09.008_bb0315","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/S0021-9258(19)75338-1","article-title":"A naturally occurring inhibitor of mitochondrial adenosine triphosphatase","volume":"238","author":"Pullman","year":"1963","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2014.09.008_bb0250","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.mito.2014.09.008_bb0255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4331\/wjbc.v1.i5.181","article-title":"Physio-pathological roles of transglutaminase-catalyzed reactions","volume":"1","author":"Ricotta","year":"2010","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.mito.2014.09.008_bb0260","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00726-011-0899-x","article-title":"TG2 transamidating activity acts as a rheostat controlling the interplay between apoptosis and autophagy","volume":"42","author":"Rossin","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.mito.2014.09.008_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2014.106","article-title":"Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis","author":"Rossin","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mito.2014.09.008_bb9005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006549","article-title":"Huntington's disease: molecular basis of neurode-generation","volume":"5","author":"Rubinsztein","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.mito.2014.09.008_bb0270","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00726-008-0130-x","article-title":"Some lessons from the tissue transglutaminase knockout mouse","volume":"36","author":"Sarang","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.mito.2014.09.008_bb0275","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0955-0674(03)00070-X","article-title":"Staying in aerobic shape: how the structural integrity of mitochondria and mitochondrial DNA is maintained","volume":"15","author":"Scott","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mito.2014.09.008_bb0280","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbadis.2009.09.013","article-title":"Abnormal mitochondrial dynamics and neurodegenerative diseases","volume":"1802","author":"Su","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2014.09.008_bb0285","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/sj.cdd.4401889","article-title":"Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia\/reperfusion injury by regulating ATP synthesis","volume":"13","author":"Szondy","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mito.2014.09.008_bb0290","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","article-title":"Fission and selective fusion govern mitochondrial segregation and elimination by autophagy","volume":"27","author":"Twig","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.mito.2014.09.008_bb0295","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1242\/dmm.016527","article-title":"Phenotypic rescue of a Drosophila model of mitochondrial ANT1 disease","volume":"7","author":"Vartiainen","year":"2014","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.mito.2014.09.008_bb0300","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/ddn404","article-title":"Effects of overexpression of huntingtin proteins on mitochondrial integrity","volume":"18","author":"Wang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2014.09.008_bb0310","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2741\/1863","article-title":"The role of tissue transglutaminase in cell\u2013matrix interactions","volume":"11","author":"Zemskov","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.mito.2014.09.008_bb0305","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbrc.2013.11.072","article-title":"Downregulation of dynamin-related protein 1 attenuates glutamate-induced excitotoxicity via regulating mitochondrial function in a calcium dependent manner in HT22 cells","volume":"443","author":"Zhang","year":"2014","journal-title":"Biochem. Biophys."}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724914001317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724914001317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T04:21:26Z","timestamp":1650255686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724914001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":64,"alternative-id":["S1567724914001317"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2014.09.008","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 Transglutaminase, mitochondria and Huntington's disease: Menage a trois","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2014.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}